VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $18.7B
- YoY, 2025
- +13.7%
- 5-year CAGR
- +16.5%
- 10-year CAGR
- +34.8%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $18.7B | +13.7% |
| 2024 | $16.4B | −6.7% |
| 2023 | $17.6B | +26.4% |
| 2022 | $13.9B | +37.7% |
| 2021 | $10.1B | +16.3% |
| 2020 | $8.7B | +42.8% |
| 2019 | $6.1B | +37.2% |
| 2018 | $4.4B | +118.6% |
| 2017 | $2.0B | +75.4% |
| 2016 | $1.2B | +23.0% |
| 2015 | $940M | −12.6% |
| 2014 | $1.1B | −20.7% |
| 2013 | $1.4B | +35.8% |
| 2012 | $999M | +27.0% |
| 2011 | $787M | +56.1% |
| 2010 | $504M | −54.0% |
| 2009 | $1.1B | +359.0% |
| 2008 | $239M | — |